Home/Pipeline/Aesthetic Implant

Aesthetic Implant

Breast Reconstruction

Pre-clinicalActive

Key Facts

Indication
Breast Reconstruction
Phase
Pre-clinical
Status
Active
Company

About Brinter

Brinter is a private, pre-revenue biotech firm developing a proprietary 3D bioprinting platform for the mass manufacturing of personalized, regenerative tissue implants. The company's initial pipeline focuses on high-failure-rate orthopedic repairs (e.g., rotator cuff, Achilles tendon, ACL) and aesthetic reconstructions, aiming to improve healing outcomes through biomimetic design and patient-specific biologics. Led by serial entrepreneurs and advised by key orthopedic surgeons, Brinter is positioning itself at the intersection of advanced manufacturing, digital health, and regenerative medicine, with the long-term vision of progressing from orthopedic implants to complex organs.

View full company profile

About Brinter

Brinter is a private, pre-revenue biotech firm developing a proprietary 3D bioprinting platform for the mass manufacturing of personalized, regenerative tissue implants. The company's initial pipeline focuses on high-failure-rate orthopedic repairs (e.g., rotator cuff, Achilles tendon, ACL) and aesthetic reconstructions, aiming to improve healing outcomes through biomimetic design and patient-specific biologics. Led by serial entrepreneurs and advised by key orthopedic surgeons, Brinter is positioning itself at the intersection of advanced manufacturing, digital health, and regenerative medicine, with the long-term vision of progressing from orthopedic implants to complex organs.

View full company profile

About Brinter

Brinter is a private, pre-revenue biotech firm developing a proprietary 3D bioprinting platform for the mass manufacturing of personalized, regenerative tissue implants. The company's initial pipeline focuses on high-failure-rate orthopedic repairs (e.g., rotator cuff, Achilles tendon, ACL) and aesthetic reconstructions, aiming to improve healing outcomes through biomimetic design and patient-specific biologics. Led by serial entrepreneurs and advised by key orthopedic surgeons, Brinter is positioning itself at the intersection of advanced manufacturing, digital health, and regenerative medicine, with the long-term vision of progressing from orthopedic implants to complex organs.

View full company profile